Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo.

Similar presentations


Presentation on theme: "Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo."— Presentation transcript:

1 Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo Clinic Proceedings  Volume 89, Issue 12, Pages (December 2014) DOI: /j.mayocp Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

2 Figure Overdose deaths involving opioid analgesics, cocaine, and heroin, United States, Not all overdose deaths specify the drug(s) involved, and a death may involve more than one specific substance. The increase in in opioid deaths is related to nonpharmaceutical fentanyl.12 ∗Heroin includes opium. Data from the Centers for Disease Control and Prevention.13 Mayo Clinic Proceedings  , DOI: ( /j.mayocp ) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo."

Similar presentations


Ads by Google